Growth In IVF Procedures Driving Preimplantation Genetic Testing Market Expansion Driver: A Major Catalyst in the Evolution of the Preimplantation Genetic Testing Market in 2025

What market dynamics are playing a key role in accelerating the growth of the preimplantation genetic testing market?
The preimplantation genetic testing market is set to gain growth momentum due to the rising number of in vitro fertilization (IVF) procedures. IVF involves the fertilization of an egg with sperm outside the body, forming an embryo, which is then placed in the uterus. This surge in IVF procedures can be attributed to advancements in reproductive technology, escalating infertility rates, and increased public awareness. The uptick in the use of IVF procedures is escalating demand for genetic testing of embryos prior to implantation, thus fuelling the market for preimplantation genetic testing. This is exemplified by data from the Society for Assisted Reproductive Technology, a US-based organization which showed that in 2022, 91,771 babies were born as a result of IVF procedures. Therefore, the rise in IVF procedures is a key driver of the preimplantation genetic testing market.

Get Your Preimplantation Genetic Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/preimplantation-genetic-testing-global-market-report

How will the growth rate of the preimplantation genetic testing market shape industry trends by 2034?
The scale of the preimplantation genetic testing market has expanded at a swift pace in the past few years. Its growth will jump from $0.83 billion in 2024 to $0.92 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. The exponential growth seen in the historical period can be credited to the escalated occurrence of genetic disorders, the rising consciousness around genetic testing, the expanding range of prenatal testing options, the mounting demand for tailored medicine, and the enhanced concentration on preventive healthcare.

Expectations suggest a speedy expansion of the preimplantation genetic testing market in the coming years, with predictions of a rise to $1.41 billion by 2029, projecting a compound annual growth rate (CAGR) of 11.2%. This anticipated surge during the forecasted period can be linked to a number of factors such as the increasing presence of fertility clinics, the expansion in genetic counseling services, rising instances of advanced maternal age, improved availability of sophisticated genetic testing platforms, and broader PGT applications. The forecast period also highlights certain key trends such as the adoption of progressive sequencing technologies, the use of comprehensive genetic panels, the inception of non-invasive testing methodologies, enhancements in embryo culture systems, and progress in genetic editing technologies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20596&type=smp

What trends are poised to drive the future success of the preimplantation genetic testing market?
Leading entities in the preimplantation genetic testing market are focusing on the development of superior next-generation sequencing (NGS) tools to boost precision, efficacy, and speed in genetic screening. These enhancements allow a more inclusive analysis and provide reliable information for would-be parents. NGS tools are transforming genetic studies with their swift, high-throughput examination of DNA and RNA. They offer intricate details about genetic variants and gene expression, boosting precision and paving the way for individualized medicine. For instance, Thermo Fisher Scientific, an American biotechnology firm, introduced the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit in July 2023. These innovative NGS tools aim to boost IVF and ICSI studies. These tests simplify the workflow from sample preparation to aneuploidy examination with their advanced technology on the ion torrent genexus integrated sequencer. This marks a noteworthy progression in the preimplantation genetic testing market by augmenting embryo screening and enhancing the success ratio in assisted reproductive technologies.

Which primary segments of the preimplantation genetic testing market are driving growth and industry transformations?
The preimplantation genetic testing market covered in this report is segmented -

1) By Procedure: Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis
2) By Product: Reagents And Consumables, Instruments, Software
3) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridization (FISH), Other Technologies
4) By Application: Chromosomal Abnormalities, Aneuploidy Screening, X-Linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Other Applications
5) By End User: Hospitals, Fertility Centers, Diagnostic Centers, Research Centers And Academic Labs

Subsegments:
1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing, Chromosomal Abnormalities Testing, HLA Typing for Stem Cell Transplantation

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20596

Which geographical regions are pioneering growth in the preimplantation genetic testing market?
North America was the largest region in the preimplantation genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the influential players reshaping the preimplantation genetic testing market landscape?
Major companies operating in the preimplantation genetic testing market are Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Revvity Health Science Inc., CooperSurgical Inc., Natera Inc., Progyny Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, Takara Bio Inc., MedGenome Labs Ltd., Genea Limited, Ovation Fertility, Juno Genetics Ltd., Invicta Genetics, Progenesis, Bioarray SL, PacGenomics, Reproductive Genetic Innovations LLC, SEQUENCE46 LLC

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20596&type=smp

What Is Covered In The Preimplantation Genetic Testing Global Market Report?

•Market Size Forecast: Examine the preimplantation genetic testing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the preimplantation genetic testing market for a structured understanding.
•Key Players Overview: Analyze major players in the preimplantation genetic testing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the preimplantation genetic testing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the preimplantation genetic testing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the preimplantation genetic testing market.
•Industry Challenges: Identify potential risks and obstacles affecting the preimplantation genetic testing market.
•Competitive Landscape: Review strategic developments in the preimplantation genetic testing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.